Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia.
Sonali NarangYohana GhebrechristosNikki A EvensenNina MurrellSylwia JasinskiTalia H OstrowDavid Trent TeacheyElizabeth A RaetzTimothée LionnetMatthew T WitkowskiIannis AifantisAristotelis TsirigosWilliam L CarrollPublished in: Nature communications (2024)
Relapsed pediatric B-cell acute lymphoblastic leukemia (B-ALL) remains one of the leading causes of cancer mortality in children. We performed Hi-C, ATAC-seq, and RNA-seq on 12 matched diagnosis/relapse pediatric leukemia specimens to uncover dynamic structural variants (SVs) and 3D chromatin rewiring that may contribute to relapse. While translocations are assumed to occur early in leukemogenesis and be maintained throughout progression, we discovered novel, dynamic translocations and confirmed several fusion transcripts, suggesting functional and therapeutic relevance. Genome-wide chromatin remodeling was observed at all organizational levels: A/B compartments, TAD interactivity, and chromatin loops, including some loci shared by 25% of patients. Shared changes were found to drive the expression of genes/pathways previously implicated in resistance as well as novel therapeutic candidates, two of which (ATXN1 and MN1) we functionally validated. Overall, these results demonstrate chromatin reorganization under the selective pressure of therapy and offer the potential for discovery of novel therapeutic interventions.
Keyphrases
- genome wide
- acute lymphoblastic leukemia
- dna methylation
- rna seq
- copy number
- single cell
- allogeneic hematopoietic stem cell transplantation
- gene expression
- acute myeloid leukemia
- dna damage
- end stage renal disease
- transcription factor
- ejection fraction
- poor prognosis
- bone marrow
- chronic kidney disease
- young adults
- free survival
- physical activity
- papillary thyroid
- peritoneal dialysis
- childhood cancer
- type diabetes
- diffuse large b cell lymphoma
- cardiovascular events
- climate change
- stem cells
- high throughput
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- patient reported
- metal organic framework
- genome wide association study